The political opponents of Coalition Avenir Québec Leader François Legault took aim at him on Friday after it was revealed his government awarded a major American consulting firm $35,000 a day for strategies on managing the COVID-19 pandemic.
The leaders of the four other main parties say the decision to award millions in sole-source contracts to the global consulting firm—and the lack of clarity about the influence the company had on the Legault cabinet—reflects a broader lack of transparency in the CAQ government.
Conservative Leader Éric Duhaime said he wants a public inquiry into the contracts given to McKinsey.
Legault defended the contracts, saying that McKinsey is widely used by other governments and in the private sector.
“It’s expensive, McKinsey, but, obviously, that’s in line with the service they provide,” Legault told reporters in Amos, Que., around 600 kilometres northwest of Montreal. The decision to award the contracts to the company came from the public service—not the cabinet—Legault said, adding that the urgency of the situation justified awarding consulting contracts without a public procurement process.
“Ultimately, it was up to me and my team to make decisions, but I think the recommendations that we received from McKinsey helped us save lives,” he said.
Liberal Leader Dominique Anglade, a former McKinsey consultant, said the contracts are a sign of the Legault government’s lack of transparency. “The fundamental question for me is why, as Quebecers, we were not informed about this,” she told reporters in Longueuil, Que., near Montreal.
Earlier this year, the French Senate issued a report questioning the role played by consulting firms, including McKinsey, in the country’s pandemic response and warning that the contracts create the possibility of conflicts of interest. In April, French prosecutors opened an investigation into tax fraud allegations against McKinsey contained in the Senate report.
In the United States, McKinsey has faced a conflict of interest investigation in both houses of Congress because of its role advising health regulators while also working for opioid drugmakers on boosting sales of painkillers.